Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic Pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte macrophage colony stimulating factor. J.Exp. Med. 190(6), 875-80,1992. PMID10499925
Kitamura N, Ohkouchi S, Tazawa R, et al. Incidence of autoimmune pulmonary alveolar proteinosis estimated using Poisson distribution. ERJ Open Res 2019; 5: 00190-2018.PMID30895185
Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of autoimmune pulmonary alveolar proteinosis patients in Japan. Am J Respir Crit Care Med 2008; 177: 752–762. PMID18202348
Ishii H, Seymour JF, Tazawa R, et al. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan. BMC Pulmonary Medicine 2014, 14:37 PMID24597668
Nakata K, Sugi T, Kuroda K, et al. Validation of a new serum
granulocyte–macrophage colony-stimulating factor autoantibody testing kit. ERJ Open Res 2020; 6:00259-2019 PMID32010720
Tazawa R, Ueda T, Abe M, et al. Inhaled GM-CSF for pulmonary alveolar proteinosis. N Engl J Med 2019; 381:923–932 PMID31483963
